{"id":1201419,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-18","captureTimestamp":"2026-03-18T07:27:56.323000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html?wbdisable=false","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1201419","browseUrl":"https://replay.healtharchive.ca/job-8/20260318072756/https://cihr-irsc.gc.ca/e/53213.html?wbdisable=false#ha_snapshot=1201419","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}